BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25081338)

  • 21. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
    Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
    Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
    Desideri E; Vegliante R; Ciriolo MR
    Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
    Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
    Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
    Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
    Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
    Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
    Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
    Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
    Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
    Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of polymorphisms in lncRNA-
    Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
    Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
    Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.
    Liu F; Luo L; Liu Z; Wu S; Zhang W; Li Q; Peng Y; Wei Y; Li B
    Mol Carcinog; 2020 Nov; 59(11):1243-1255. PubMed ID: 32869896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma.
    Xie K; Liu J; Zhu L; Liu Y; Pan Y; Wen J; Ma H; Zhai X; Hu Z
    Cancer Epidemiol; 2013 Dec; 37(6):998-1002. PubMed ID: 24103425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
    Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
    Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma.
    Xie CR; Sun HG; Sun Y; Zhao WX; Zhang S; Wang XM; Yin ZY
    Mol Med Rep; 2015 Sep; 12(3):4203-4209. PubMed ID: 26095787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.